Chemoinformaics analysis of Lavandulyl 2-methyl butanoate
| Molecular Weight | 238.371 | nRot | 7 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 1 |
| Exact Molecular Weight | 238.193 | nRing | 0 |
| Solubility: LogS | -6.254 | nHRing | 0 |
| Solubility: LogP | 6.426 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.9906 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.358 |
| Synth | 2.344 |
| Natural Product Likeliness | 0.671 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.318 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.624 |
| MDCK | 0.0000164 |
| BBB | 0.466 |
| PPB | 0.969865 |
| VDSS | 1.126 |
| FU | 0.0177537 |
| CYP1A2-inh | 0.892 |
| CYP1A2-sub | 0.305 |
| CYP2c19-inh | 0.55 |
| CYP2c19-sub | 0.264 |
| CYP2c9-inh | 0.462 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.105 |
| CYP2d6-sub | 0.059 |
| CYP3a4-inh | 0.466 |
| CYP3a4-sub | 0.116 |
| CL | 6.319 |
| T12 | 0.327 |
| hERG | 0.086 |
| Ames | 0.005 |
| ROA | 0.021 |
| SkinSen | 0.949 |
| Carcinogencity | 0.077 |
| EI | 0.952 |
| Respiratory | 0.899 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.799005 |